- CLINICAL BRIEFINGS
Through comprehensive genomic and immune analyses, mechanisms of lung cancer resistance after treatment with EGFR inhibition and vaccine therapy were investigated. This case report, together with data from the longitudinal lung cancer study TRACERx, highlight the importance of understanding when targeted variants are acquired during the cancer’s evolutionary history.
You Might Also Like
How leading a postdoc network boosted my career prospects
PostdocNet represents several thousand postdocs at the Max Planck institutes and provides opportunities for professional development and community building.Credit: Swen...
Woman in cancer remission for record 19 years after CAR-T immune treatment
A CAR-T cell (orange) has attacks a cancer cell (green), which is starting to contract.Credit: Eye Of Science/Science Photo LibraryThe...
scientific storytelling from a recovering academic
Cave-bat fieldwork often looked like a scene from the 1995 film Outbreak.Credit: Warner Bros/AJ Pics/AlamyFor years, I was a bat...
Scientists fight Norway’s language law, warning of talent exodus
The Norwegian government wants to ensure that English does not replace Norwegian as the main language used in higher education.Credit:...